V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014846 | 160007326 | 1.66 | 54.7 | Palliative (P) | 2017-04-24 | 2017-04-27 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101634126 |
| 160014848 | 160007327 | 1.74 | 64.8 | Palliative (P) | 2018-07-19 | 2018-08-02 | Cisplatin + Pemetrexed | 02 | N | VIDE | 100422321 |
| 160014850 | 160007328 | 1.67 | 67.6 | Palliative (P) | 2019-11-10 | 2019-11-15 | LENVATINIB | N | N | NOT MATCHED | 101313616 |
| 160014851 | 160007329 | 1.7 | 59.7 | Palliative (P) | 2016-10-27 | 2016-11-04 | EW EuroEwing 2012 Arm B IE | 02 | N | PACLITAXEL | 101703111 |
| 160014854 | 160007330 | 1.7 | 84.6 | Palliative (P) | 2018-06-22 | 2018-06-27 | Liposomal Doxorubicin (Caelyx) | 02 | N | CISPLATIN + PEMETREXED | 100565074 |
| 160014855 | 160007331 | 1.84 | 88 | Curative (C) | 2020-03-01 | 2020-04-13 | Trial Unspecified | N | N | TRIAL UNSPECIFIED | 101496455 |
| 160014858 | 160007332 | 1.76 | 102 | Palliative (P) | 2019-11-23 | 2019-12-07 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100317216 |
| 160014859 | 160007333 | 1.79 | 56 | Neo-adjuvant (N) | 2019-01-08 | 2019-02-06 | STS Rhabdomyosarco RMS 2005 IVADoVV | 2 | N | TRIAL UNSPECIFIED | 101378710 |
| 160014860 | 160007334 | 1.75 | 76.9 | Palliative (P) | 2017-03-15 | 2017-04-12 | DOXORUBICIN | 2 | N | CISPLATIN + ETOPOSIDE | 101077483 |
| 160014862 | 160007335 | 1.65 | 64.2 | Palliative (P) | 2019-02-23 | 2019-02-23 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | DOXORUBICIN | 100109386 |
| 160014864 | 160007336 | 1.72 | 68.4 | null | 2019-05-27 | 2019-06-03 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100911366 |
| 160014865 | 160007337 | 1.52 | 90 | Curative (C) | 2020-09-16 | 2020-09-24 | VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 100956908 |
| 160014866 | 160007338 | 1.7 | 54.45 | Palliative (P) | 2019-10-07 | 2019-11-05 | Bevacizumab | 02 | N | DOXORUBICIN + OLARATUMAB | 100101936 |
| 160014867 | 160007339 | 1.64 | 53.6 | Curative (C) | 2018-07-10 | 2018-08-01 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101225189 |
| 160014868 | 160007340 | 1.58 | 72.6 | Palliative (P) | 2016-05-09 | 2016-05-26 | CARBOPLATIN + PACLITAXEL | 99 | N | CARBOPLATIN + PACLITAXEL | 100126690 |
| 160014869 | 160007341 | 1.72 | 82 | null | 2017-07-01 | 2017-07-14 | null | 02 | N | ECX | 101443326 |
| 160014871 | 160007342 | 1.6 | 27 | Palliative (P) | 2019-03-25 | 2019-03-25 | Paclitaxel 80mg/m2 day 1 8 15 | 01 | N | DOXORUBICIN + IFOSFAMIDE | 101263667 |
| 160014872 | 160007343 | 1.64 | 80 | null | 2017-09-28 | 2017-10-13 | Cisplatin + Etoposide (3 day) | null | N | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 101207955 |
| 160014874 | 160007344 | 1.77 | 88.8 | Neo-adjuvant (N) | 2018-02-28 | 2018-02-28 | Bevacizumab | N | N | PEMETREXED | 101364953 |
| 160014875 | 160007345 | 1.76 | 60.8 | Palliative (P) | 2018-09-15 | 2018-09-29 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101218813 |
| 160014876 | 160007346 | 1.76 | 79 | Palliative (P) | 2018-10-20 | 2018-11-23 | Doxorubicin 75mg/m2 | 02 | N | IVADO | 101131883 |
| 160014877 | 160007347 | 1.54 | 59.9 | Neo-adjuvant (N) | 2019-01-29 | 2019-02-11 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101794233 |
| 160014878 | 160007348 | 1.56 | 58.5 | Palliative (P) | 2019-09-14 | 2019-09-14 | Doxorubicin + Ifosfamide | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100653598 |
| 160014879 | 160007349 | null | null | Palliative (P) | 2018-09-14 | 2018-09-14 | Hydroxycarbamide | N | null | STS NON-RHABDO EPSSG 2005 IVA | 100761287 |
| 160014887 | 160007350 | 1.74 | 84.2 | Palliative (P) | 2019-10-05 | 2019-10-06 | Carboplatin AUC 2 - 5 | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100759124 |
| 160014889 | 160007351 | 1.84 | 102 | Palliative (P) | null | 2018-09-27 | Doxorubicin + Ifosfamide | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 101311602 |
| 160014891 | 160007352 | 1.57 | 68.3 | Palliative (P) | 2017-04-12 | 2017-04-12 | VINORELBINE | 02 | N | CARBOPLATIN + PACLITAXEL | 101812067 |
| 160014894 | 160007353 | 1.76 | 70 | Palliative (P) | 2018-01-15 | 2018-02-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101514523 |
| 160014897 | 160007355 | 1.63 | 113.1 | Palliative (P) | 2016-02-08 | 2016-02-18 | BEP 3 day | 02 | N | ABIRATERONE | 101459950 |
| 160014899 | 160007356 | 1.59 | 100.5 | Palliative (P) | 2017-11-22 | 2017-12-06 | Etoposide + Ifosfamide (3 days) | 02 | N | DOXORUBICIN | 100136158 |
| 160014901 | 160007357 | 1.87 | 52.6 | Palliative (P) | 2016-06-16 | 2016-06-16 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100914478 |
| 160014905 | 160007358 | null | null | Curative (C) | 2020-10-17 | 2020-10-24 | Doxorubicin + Ifosfamide | 01 | Y | DOXORUBICIN | 100660134 |
| 160014906 | 160007359 | 1.65 | null | Curative (C) | 2019-10-23 | 2019-10-31 | EW EuroEwing 2012 Arm B VDC | 02 | N | LIPOSOMAL DOXORUBICIN | 101366873 |
| 160014908 | 160007360 | 1.52 | 77.1 | Curative (C) | 2018-02-05 | 2018-03-18 | Doxorubicin 75mg/m2 | 01 | N | DOXORUBICIN | 100351570 |
| 160014911 | 160007361 | 1.81 | 70.2 | Palliative (P) | 2016-08-14 | 2016-09-27 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100164057 |
| 160014912 | 160007362 | 1.69 | 79.9 | Palliative (P) | 2017-12-23 | 2018-01-05 | Doxorubicin 75mg/m2 | 01 | N | DOXORUBICIN | 100678496 |
| 160014917 | 160007363 | 1.51 | 83.5 | Disease modification (D) | null | 2019-02-13 | Doxorubicin + Ifosfamide | 02 | N | TRIAL UNSPECIFIED | 101635913 |
| 160014919 | 160007364 | 1.65 | 54.1 | Neo-adjuvant (N) | 2017-11-07 | 2017-11-12 | EW EuroEwing 2012 Arm A VIDE | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101531265 |
| 160014921 | 160007365 | 1.58 | 97 | null | null | 2016-10-09 | CARBOPLATIN + PACLITAXEL | N | N | CARBOPLATIN + PACLITAXEL | 100894640 |
| 160014923 | 160007366 | 1.66 | 96.6 | Palliative (P) | 2017-03-06 | 2017-04-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100973948 |
| 160014924 | 160007367 | 1.8 | 76.3 | Palliative (P) | null | 2019-02-19 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 100296702 |
| 160014925 | 160007368 | 1.69 | 55 | Adjuvant (A) | null | 2017-08-07 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 100999250 |
| 160014927 | 160007369 | 1.64 | 84.9 | Palliative (P) | 2018-07-21 | 2018-07-24 | DOXORUBICIN | N | N | CARBOPLATIN | 100007582 |
| 160014928 | 160007370 | 1.68 | 60.8 | Palliative (P) | 2018-07-02 | 2018-07-12 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 101050204 |
| 160014930 | 160007371 | null | null | Palliative (P) | 2019-03-28 | 2019-04-17 | GEMCITABINE + RT | N | null | DOXORUBICIN | 101121298 |
| 160014932 | 160007372 | 1.68 | 79.2 | Adjuvant (A) | 2019-04-19 | 2019-04-19 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100139141 |
| 160014934 | 160007373 | 1.62 | 74 | Adjuvant (A) | null | 2018-08-02 | null | 02 | N | PACLITAXEL | 100201377 |
| 160014936 | 160007374 | 1.69 | 57.2 | Neo-adjuvant (N) | 2016-05-13 | 2016-06-03 | Doxorubicin + Ifosfamide | null | N | NOT MATCHED | 100734876 |
| 160014938 | 160007375 | 1.77 | 93 | Neo-adjuvant (N) | 2019-03-05 | 2019-03-11 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 101468234 |
| 160014939 | 160007376 | 1.6 | 85.8 | Curative (C) | 2019-11-01 | 2019-11-02 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 100143832 |